细胞瘤-话题@MedSci

#细胞瘤#

460篇内容 | 6514人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1476160, encodeId=40be14e616020, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=GD2抗体达妥昔单抗β治疗神经母细胞瘤的临床应用专家共识(2021年版), objectType=article, longId=295271, objectId=9ef32952e172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ef32952e172, replyNumber=0, likeNumber=62, createdTime=2022-02-10, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ef32952e172, moduleTitle=GD2抗体达妥昔单抗β治疗神经母细胞瘤的临床应用专家共识(2021年版), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ef32952e172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476159, encodeId=f81514e615945, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤的疗效, objectType=article, longId=295055, objectId=f6e229505515, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e229505515, replyNumber=0, likeNumber=84, createdTime=2022-02-04, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e229505515, moduleTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e229505515)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476158, encodeId=f43814e61589a, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=知临集团用于治疗神经母细胞瘤的再利用药物 SACT-1 获得FDA孤儿药资格, objectType=article, longId=294441, objectId=374b2944415a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=374b2944415a, replyNumber=0, likeNumber=80, createdTime=2022-01-23, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=374b2944415a, moduleTitle=知临集团用于治疗神经母细胞瘤的再利用药物 SACT-1 获得FDA孤儿药资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=374b2944415a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476157, encodeId=685314e61579c, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=知临集团SACT-1 再利用药物获首项专利治疗神经母细胞瘤等癌症, objectType=article, longId=294292, objectId=1edf294292d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1edf294292d6, replyNumber=0, likeNumber=77, createdTime=2022-01-21, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1edf294292d6, moduleTitle=知临集团SACT-1 再利用药物获首项专利治疗神经母细胞瘤等癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1edf294292d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476156, encodeId=ca6314e6156c4, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=知临集团宣布完成针对金黄色葡萄球菌和神经母细胞瘤感染的小分子药物ALS-4和SACT-1的I期临床试验, objectType=article, longId=293895, objectId=2b072938950e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b072938950e, replyNumber=0, likeNumber=118, createdTime=2022-01-14, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b072938950e, moduleTitle=知临集团宣布完成针对金黄色葡萄球菌和神经母细胞瘤感染的小分子药物ALS-4和SACT-1的I期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b072938950e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476155, encodeId=400a14e615554, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=ASCO-2021速递：光谱MRI可指导胶质母细胞瘤放疗，安全有效, objectType=article, longId=293013, objectId=9da72930139e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9da72930139e, replyNumber=0, likeNumber=79, createdTime=2021-12-30, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9da72930139e, moduleTitle=ASCO-2021速递：光谱MRI可指导胶质母细胞瘤放疗，安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9da72930139e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476154, encodeId=353f14e615491, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Lancet oncol：替莫唑胺辅助治疗可改善放疗后的间变性胶质细胞瘤患者的生存预后！, objectType=article, longId=293001, objectId=3e2e29300136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e2e29300136, replyNumber=0, likeNumber=89, createdTime=2021-12-30, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e2e29300136, moduleTitle=Lancet oncol：替莫唑胺辅助治疗可改善放疗后的间变性胶质细胞瘤患者的生存预后！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e2e29300136)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476153, encodeId=005714e615398, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Science Advances：DNA纳米管，突破血脑屏障，为胶质母细胞瘤带来希望, objectType=article, longId=292636, objectId=bf6429263659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf6429263659, replyNumber=0, likeNumber=66, createdTime=2021-12-25, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf6429263659, moduleTitle=Science Advances：DNA纳米管，突破血脑屏障，为胶质母细胞瘤带来希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf6429263659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476152, encodeId=fe6914e615214, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Nat Commun：p32 CAR-T细胞：胶质母细胞瘤的潜在治疗选择, objectType=article, longId=292171, objectId=e81a2921e11f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e81a2921e11f, replyNumber=0, likeNumber=102, createdTime=2021-12-19, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e81a2921e11f, moduleTitle=Nat Commun：p32 CAR-T细胞：胶质母细胞瘤的潜在治疗选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e81a2921e11f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476151, encodeId=099314e615137, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Nat Commun：“以毒攻毒”，溶瘤病毒增强了对胶质母细胞瘤的抗肿瘤先天免疫反应, objectType=article, longId=292169, objectId=c21f292169bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c21f292169bd, replyNumber=0, likeNumber=68, createdTime=2021-12-19, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c21f292169bd, moduleTitle=Nat Commun：“以毒攻毒”，溶瘤病毒增强了对胶质母细胞瘤的抗肿瘤先天免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c21f292169bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476150, encodeId=28e314e6150e1, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, objectType=article, longId=292166, objectId=891e29216606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=891e29216606, replyNumber=0, likeNumber=71, createdTime=2021-12-19, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=891e29216606, moduleTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=891e29216606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476149, encodeId=5ee914e6149a7, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤, objectType=article, longId=292164, objectId=e7c829216496, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7c829216496, replyNumber=0, likeNumber=70, createdTime=2021-12-19, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7c829216496, moduleTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7c829216496)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476148, encodeId=b27e14e6148a3, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=复发胶质母细胞瘤病例分享, objectType=article, longId=221121, objectId=2309221121e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2309221121e9, replyNumber=0, likeNumber=70, createdTime=2021-11-28, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2309221121e9, moduleTitle=复发胶质母细胞瘤病例分享, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2309221121e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476147, encodeId=e98314e6147c1, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, objectType=article, longId=220476, objectId=41ac2204e60d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41ac2204e60d, replyNumber=0, likeNumber=107, createdTime=2021-11-18, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41ac2204e60d, moduleTitle=Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41ac2204e60d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476146, encodeId=925214e614672, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤, objectType=article, longId=220259, objectId=ae6b22025996, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae6b22025996, replyNumber=0, likeNumber=97, createdTime=2021-11-14, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae6b22025996, moduleTitle=Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae6b22025996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476183, encodeId=eb1214e618354, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=【PHILIPS每日一例】鞍旁脑膜血管周细胞瘤1例, objectType=article, longId=290244, objectId=ee812902441f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee812902441f, replyNumber=0, likeNumber=83, createdTime=2021-11-10, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee812902441f, moduleTitle=【PHILIPS每日一例】鞍旁脑膜血管周细胞瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee812902441f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476182, encodeId=7d0714e6182fa, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=【CLEAR柯丽尔每日一例】肝脏血管周上皮样细胞瘤, objectType=article, longId=288573, objectId=5fb42885e3a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fb42885e3a6, replyNumber=0, likeNumber=82, createdTime=2021-11-10, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fb42885e3a6, moduleTitle=【CLEAR柯丽尔每日一例】肝脏血管周上皮样细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fb42885e3a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476178, encodeId=4f6714e617862, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=加深印象 — 食管、胃炎性肌纤维母细胞瘤1例, objectType=article, longId=244258, objectId=b7fd244258fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7fd244258fa, replyNumber=0, likeNumber=70, createdTime=2021-11-07, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7fd244258fa, moduleTitle=加深印象 — 食管、胃炎性肌纤维母细胞瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7fd244258fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476145, encodeId=003a14e61458d, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究, objectType=article, longId=219464, objectId=7756219464f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7756219464f4, replyNumber=0, likeNumber=100, createdTime=2021-10-30, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7756219464f4, moduleTitle=Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7756219464f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476144, encodeId=61f814e614472, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Nat Commun：“以毒攻毒”，溶瘤病毒增强了对胶质母细胞瘤的抗肿瘤先天免疫反应, objectType=article, longId=218319, objectId=2d892183196e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d892183196e, replyNumber=0, likeNumber=81, createdTime=2021-10-11, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d892183196e, moduleTitle=Nat Commun：“以毒攻毒”，溶瘤病毒增强了对胶质母细胞瘤的抗肿瘤先天免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d892183196e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞瘤

2020-05-29

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

GD2抗体达妥昔单抗β治疗神经母细胞瘤的临床应用专家共识(2021年版)

2022-02-10

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤的疗效

2022-02-04

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

知临集团用于治疗神经母细胞瘤的再利用药物 SACT-1 获得FDA孤儿药资格

2022-01-23

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

知临集团SACT-1 再利用药物获首项专利治疗神经母细胞瘤等癌症

2022-01-21

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

知临集团宣布完成针对金黄色葡萄球菌和神经母细胞瘤感染的小分子药物ALS-4和SACT-1的I期临床试验

2022-01-14

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

ASCO-2021速递：光谱MRI可指导胶质母细胞瘤放疗，安全有效

2021-12-30

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Lancet oncol：替莫唑胺辅助治疗可改善放疗后的间变性胶质细胞瘤患者的生存预后！

2021-12-30

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Science Advances：DNA纳米管，突破血脑屏障，为胶质母细胞瘤带来希望

2021-12-25

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Nat Commun：p32 CAR-T细胞：胶质母细胞瘤的潜在治疗选择

2021-12-19

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Nat Commun：“以毒攻毒”，溶瘤病毒增强了对胶质母细胞瘤的抗肿瘤先天免疫反应

2021-12-19

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性

2021-12-19

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤

2021-12-19

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

复发胶质母细胞瘤病例分享

2021-11-28

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Front Oncol：替莫唑胺联合阿帕替尼治疗复发性胶质母细胞瘤的疗效和安全性

2021-11-18

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Clin Cancer Res：口服Selinexor治疗复发性胶质母细胞瘤

2021-11-14

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

【PHILIPS每日一例】鞍旁脑膜血管周细胞瘤1例

2021-11-10

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

【CLEAR柯丽尔每日一例】肝脏血管周上皮样细胞瘤

2021-11-10

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

加深印象 — 食管、胃炎性肌纤维母细胞瘤1例

2021-11-07

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究

2021-10-30

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Nat Commun：“以毒攻毒”，溶瘤病毒增强了对胶质母细胞瘤的抗肿瘤先天免疫反应

2021-10-11

科室
- - 订阅+
  - 更多科室
工具
服务